Skip to content

SES AI SES Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
Asia Pacific92%-8.0%

Other financials

Income statement

See full
Revenue$6.7M+15.8%
Gross profit$1.2M-73.3%
Operating income-$17.9M+23.2%
Net income-$12.1M+2.7%
EPS (diluted)-$0.040.0%

Balance sheet

See full
Cash & equivalents$46.9M-16.3%
Total debt$7.7M-18.9%
Total equity$203.2M-24.7%
Total assets$253.5M-17.1%

Cash flow

See full
Operating cash flow-$19.8M+13.3%
CapEx$330.0K-64.0%
Free cash flow-$20.1M+15.2%

Valuation

See full
Market cap$325.08M+5.5%
Enterprise value$285.86M+9.3%
P/S14.8×-27.2×

Profitability

See full
Gross margin36.3%-39.1pp
Operating margin-352.3%-153pp
Net margin-331.7%-142pp
FCF margin-262.8%-115pp

Returns & leverage

See full
Return on equity-30.7%-0.7pp
Debt / equity0.0×
Current ratio6.9×-8.8×